|
|
 |
|
Viewing report
|
|
|
|
Chronic Obstructive Pulmonary Disease (COPD) Market: An Analysis
Koncept Analytics, May 2009, Pages: 35
In the present era, use of tobacco, polluted environment, poverty and aging population have become a major threat; all these factors account for a major cause of deaths by COPD. Market for COPD medication is growing with increasing prevalence rate worldwide and it has become the fourth leading cause of death. The number of people with COPD varies throughout world. Cape Town has the highest prevalence of COPD, while Hanover has the lowest prevalence.
In United States, its prevalence is high and geographically, its prevalence in the Southern part of the country is highest and the Northeastern part has the lowest prevalence rate. With increasing rate of COPD patients, the economic cost is also increasing, which leads to the highest economic cost out of all the lung diseases in United States.
Spiriva is the leading medication for the disease while rest of the medicines market is expected to decline in future with the effect of new developments and increasing competition. At present Advair has also a good hold in the market. Inhalers demand is high for COPD and there are few oral medicines available.
The present report analyses worldwide COPD market with prevalence of the disease in major parts of the world. It talks about United States and Australian market for the medication of COPD and mortality and death rates. Economic cost is also an important segment of the report in which we have discussed US and Australian markets. There are many factors driving the industry which are discussed in growth drivers. In future trends we have discussed the projected market condition, which may help in forming strategies.
The report also talks about the future outlook of the industry and its growth. By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Customers who bought this item also bought
Managing Chronic Obstructive Pulmonary Disease
Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease Therapy Area Pipeline Report
Respiratory and Pulmonary System - Chronic Obstructive Pulmonary Disease Drug Pipeline Report
Target Product Profiles 2008: Physician Insights on Key Attributes - Chronic Obstructive Pulmonary Disease
Disease and Therapy Review: Chronic Obstructive Pulmonary Disease
U.S. Chronic Obstructive Pulmonary Disease Drug Markets
US market size for angina, congestive heart failure and chronic obstructive pulmonary disease therapies by number of patients in 2000 forecast to 2005; also, number of CHF and COPD patients with prescription drug benefits, and users and dollar sales
Chronic Disease Management: An Investment Toward Sustainability
Pulmonary Drug Delivery Technologies - A Global Market Perspective
The Complete Directory for People with Chronic Illness 2007/08 Edition
Pulmonary Drug Delivery Technologies - Global Strategic Business Report
|
|
|
|
